title: The association of serum metabolites with clinical disease during the transition period.
abstract: The objective of this observational field study was to validate the relationship of serum concentrations of nonesterified fatty acids (NEFA), β-hydroxybutyrate (BHBA), and calcium with disease in early lactation across different management systems. Fifty-five Holstein freestall dairy herds located across the United States and Canada were selected and visited weekly for blood sample collection from 2,365 cows. Only diseases that were consistently recorded across herds and blood samples collected before the disease occurred were considered. Metabolite concentrations in serum in wk -1 relative to calving were considered as predictors of retained placenta (RP) and metritis, and metabolite concentrations in serum in wk -1 and wk +1 relative to calving were considered as predictors of displaced abomasum (DA). For each disease, each metabolite, and week of sampling in the case of DA, a critical threshold was calculated based on the highest combined sensitivity and specificity and used to categorize the serum concentrations into high and low risk categories. Multivariable logistic regression models were built for each disease of interest and week of sampling, considering cow as the experimental unit and herd as a random effect. Cows with precalving serum NEFA concentrations ≥ 0.3 mEq/L were more likely to develop RP [odds ratio (OR) = 1.8; 95% confidence interval (CI) = 1.3 to 2.6] and metritis (OR = 1.8; 95% CI = 1.5 to 2.9) after calving than cows with lower NEFA concentrations. Precalving NEFA ≥ 0.5 mEq/L (OR = 2.4; 95% CI = 1.5 to 3.7), postcalving NEFA ≥ 1.0 mEq/L (OR = 2.7; 95% CI = 1.7 to 4.4), and postcalving calcium ≤ 2.2 mmol/L (OR = 3.1; 95% CI = 1.9 to 5.0) were associated with subsequent risk of DA. In conclusion, elevated serum NEFA concentrations within 1 wk before calving were associated with increased risk of RP, metritis, and DA after calving. Serum NEFA and calcium concentrations in the 2 wk around calving in combination were associated with the risk of DA.
authors.affiliation: Department of Population Medicine, University of Guelph, Ontario, Canada, N1G 2W1; Animal Welfare Program, University of British Columbia, BC, Canada, V6T 1Z4.
authors.forename: N
authors.initials: N
authors.lastname: Chapinal
authors.forename: M
authors.initials: M
authors.lastname: Carson
authors.forename: T F
authors.initials: TF
authors.lastname: Duffield
authors.forename: M
authors.initials: M
authors.lastname: Capel
authors.forename: S
authors.initials: S
authors.lastname: Godden
authors.forename: M
authors.initials: M
authors.lastname: Overton
authors.forename: J E P
authors.initials: JE
authors.lastname: Santos
authors.forename: S J
authors.initials: SJ
authors.lastname: LeBlanc
mesh_terms: D020155:3-Hydroxybutyric Acid / Q000097:blood*; D000018:Abomasum / Q000473:pathology; D000818:Animals; D002118:Calcium / Q000097:blood*; D002170:Canada; D002417:Cattle; D002418:Cattle Diseases / Q000097:blood*; D003612:Dairying; D005230:Fatty Acids, Nonesterified / Q000097:blood*; D005260:Female; D007774:Lactation / Q000502:physiology; D016015:Logistic Models; D011237:Predictive Value of Tests; D011247:Pregnancy; D013272:Stomach Diseases / Q000097:blood / Q000662:veterinary*; D014481:United States
chemical_list: D005230:Fatty Acids, Nonesterified; D002118:Calcium; D020155:3-Hydroxybutyric Acid